相关实验视频

Updated: Jun 27, 2025

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

"Izervay (avacincaptad pegol):为在地理缩中维护视力铺平了道路"

Laiba Shakeel¹, Afsheen Khan¹, Aymar Akilimali²

¹Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.

Annals of medicine and surgery (2012)

|May 2, 2024

概括

伊泽维 (avacincaptad pegol) 是一种新的FDA批准的治疗地理缩 (GA) 二次性与年龄相关的黄斑变性 (AMD). 它抑制补充C5以减缓GA病变的生长,为维护视力提供希望.

科学领域:

眼科医生眼科眼科
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

与年龄相关的黄斑变性 (AMD) 是不可逆转的中央视力丧失的主要原因.
地理缩 (GA) 是一种严重的AMD形式,涉及由于补体系统失调导致的视网膜细胞退化.
目前对GA的有效治疗方法有限,造成了大量未满足的医疗需求.

研究的目的:

审查Izervay (avacincaptad pegol),一种新的FDA批准的治疗GA二次到AMD.
讨论Izervay的作用机制,临床疗效和安全性概况.
为了突出Izervay对管理GA和维护视力的潜在影响.

主要方法:

对avacincaptad pegol (ACP) 的临床试验数据和科学文献的审查.
针对补充级联 (C5抑制) 的Izervay机制的分析.
从临床研究中评估安全性和耐受性数据.

主要成果:

在临床试验中,Izervay证明了GA病变生长率的显著降低.
药物标补充C5蛋白,减轻了膜攻击复合物的形成.
阿瓦辛卡普塔德 (Avacincaptad pegol) 显示出一个一般可容忍的安全性概况,并具有可控的副作用.

结论:

伊泽维在治疗与AMD相关的地理缩方面取得了重大进展.
该药物提供了一种新的治疗选择,可以减缓疾病的进展并保持视力.
进一步的研究将评估这种新治疗方法的长期结果和可访问性.

关键词:

它们是Aptamers.补充 C5 补充 C5 补充补充膜攻击复杂的复杂的补充膜地理缩是地理上的缩.斑点退化症斑点退化症核酸核酸是一种核酸.

更多相关视频

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...